Trending Now
CNS Pharmaceuticals Inc (NASDAQ:CNSP) Receives IND Application for Berubicin From the...
The US FDA granted IND (Investigational New Drug) application for Berubicin of CNS Pharmaceuticals Inc (NASDAQ:CNSP) to cure GBM (Glioblastoma Multiforme).CNS will...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Investors Focus on Top Metaverse Plays as New Year Gets in...
The investing landscape for 2022 is uncertain, as we have seen over recent days. The year has started with selling driven by...
MAKE IT MODERN
LATEST REVIEWS
Curis Inc. (NASDAQ: CRIS) Expands Executive Leadership With Addition Of Three...
Curis Inc. (NASDAQ: CRIS) has expanded its executive leadership with the addition of Felix Geissler as VP of Medical Affairs, Dora Ferrari as VP...
MAKE IT MODERN
PERFORMANCE TRAINING
Outlook Therapeutics Inc. (NASDAQ:OTLK) Secures $10 Million Funding To Support BLA For ONS-5010 In...
Outlook Therapeutics Inc. (NASDAQ:OTLK) has announced the issuance of an unsecured promissory note of $10.2 million to an accredited investor for cash proceeds of...
CASI Pharmaceuticals Inc (NASDAQ:CASI) Reports A Growth Of 265% YoY In 2020
CASI Pharmaceuticals Inc (NASDAQ:CASI) reported a growth of 265% YoY to $15 million in 2020. Cost of revenues increased by 143% YoY to $9.5...
AzurRx BioPharma Inc. (NASDAQ: AZRX) Receives Approval To Commence FW-1022 study and Submits IND...
AzurRx BioPharma Inc. (NASDAQ: AZRX) has announced approval from the independent data monitoring committee to commence enrolment of patients in the second part of...
Peloton’s ($PTON) Rocky Fiscal Fourth Quarter: A Dive into Subscriber Drop and Product Recall
Shares of Peloton (NASDAQ:PTON), the renowned fitness equipment and media company, plummeted about 23% in early trading on Wednesday. The dip...
VYNE Therapeutics Inc. (NASDAQ:VYNE) Files Another Patent For AMZEEQ And Announces End-of-Phase 2 Meeting...
Vyne Therapeutics Inc. (NASDAQ:VYNE) has completed its End-of-phase 2 Meeting with the US FDA. Also, the company announced the listing of another US patent...
MAKE IT MODERN
